Global Anti-Parkinson Drugs Market Report 2020 - Opportunities And Strategies, Market Forecast And Trends
5 Nov, 2020
The global anti-Parkinson drugs market is expected to decline from $4.23 billion in 2019 to $4.12 billion in 2020 at a compound annual growth rate (CAGR) of -2.62%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $5.04 billion in 2023 at a CAGR of 7.01%.
The anti-Parkinson drugs market consists of sales of drugs used for treating Parkinson`s disease (PD), generated by the establishments that manufacture these drugs. Parkinson`s disease is a neurodegenerative disorder that affects predominately dopaminergic neurons in a specific area of the brain named substantia nigra and disturbs the movement of the body. People suffering from PD may experience tremor, bradykinesia, limb rigidity, gait, and balance problems.
Request For A Sample For The Global Anti-Parkinson Drugs Market Report:
The global anti-parkinson drugs market is further segmented based on type and geography.
By Drugs Class: Levodopa/Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics, Other Drugs.
By Route of Administration: Oral, Injection, Transdermal.
By Distribution Channel: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies.
By Geography: The global anti-parkinson drugs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, the North America anti-parkinson drugs market accounts for the largest share in the global anti-parkinson drugs market.
Read More On The Report For The Global Anti-Parkinson Drugs Market At:
Trends In The Anti-Parkinson Drugs Market
Increasing investments by governments and companies for Parkinson’s disease drug R&D is a major trend in the anti-Parkinson drugs market. For instance, according to the report published in 2018 by the Parkinson’s Foundation, the foundation awarded $6 million to Parkinson`s disease (PD) research.
Anti-Parkinson Drugs Global Market Report 2020 is one of a series of new reports from The Business Research Company that provides anti-parkinson drugs market overviews, analyzes and forecasts market size and growth for the global anti-parkinson drugs market, anti-parkinson drugs market share, anti-parkinson drugs market players, anti-parkinson drugs market segments and geographies, anti-parkinson drugs market’s leading competitors’ revenues, profiles and market shares. The anti-parkinson drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.